Skip to main content

Table 1 Antimicrobial susceptibility profile of S. aureus

From: Characterization of Staphylococcus aureus isolated from patients with burns in a regional burn center, Southeastern China

Antimicrobial

S.aureus in SSTI (n = 75)

S.aureus in non-SSTI (n = 50)

R(%)

I(%)

S(%)

R(%)

I(%)

S(%)

Penicillin G

93.3

0.0

6.7

84.0

0.0

16.0

Cefoxitin Screen

90.7

0.0

9.3

62.0

0.0

38.0

Oxacillin

88.0

0.0

12.0

60.0

0.0

40.0

Gentamicin

60.0

2.7

37.3

38.0

2.0

60.0

Ciprofloxin

62.7

2.7

34.6

64.0

2.0

34.0

Levofloxacin

42.7

1.3

56.0

52.0

4.0

44.0

Moxifloxacin

25.3

4.0

70.7

34.0

4.0

62.0

Clindamycin

78.7

2.7

18.6

54.0

2.0

44.0

Erythromycin

90.7

2.7

6.6

50.0

4.0

46.0

Tetracycline

72.0

1.3

26.7

50.0

2.0

48.0

Rifampicin

49.3

2.7

48.0

30.0

2.0

68.0

Quinupristin/Dalfopristin

0.0

0.0

100.0

0.0

0.0

100.0

Trimethoprim/Sulfamethoxazole

18.7

0.0

81.3

16.0

0.0

84.0

Tigecycline

1.3

0.0

98.7

2.0

0.0

98.0

Nitrofurantoin

0.0

0.0

100.0

0.0

0.0

100.0

Linezolid

0.0

0.0

100.0

0.0

0.0

100.0

Vancomycin

0.0

0.0

100.0

0.0

0.0

100.0

  1. SSTI, skin and soft tissue infection